With the recently granted FDA clearance Covidien provides a new warning technology that, we early warning of physiological conditions with a high respiratory problems may provide. This enables clinicians to intervene sooner and improve prospects .. The OxiMax SPD feature enables the pulse oximeter to detect and alert clinicians worrisome oxygen desaturation patterns, make make timely and informed decisions about patient care. The demand for continuous pulse oximetry monitoring – especially for patients taking opioids – is increasing in all areas of the hospital , and is an important part of balancing patient safety and pain management, said Roger Mecca, vice president, Medical Affairs, Respiratory and monitoring Solutions, Covidien.
Covidien manufactures, distributes and services a diverse range of industry-leading product lines in four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products and Medical Supplies. With 2008 revenue of nearly $ 10 billion, Covidien has more than 41,000 employees worldwide in 59 countries, and in over 140 countries in over 140 countries. Please visit to learn more about our company. – 1 Opioids and Code Blue Emergencies, Joyner and D. Pfeiffer, Anesthesiology 2008, 109 A34.. Detecting repetitive reductions in air flow is an important measure of a patient’s respiratory status and requires close monitoring in high risk patients, such as: with Equipped – recovering from surgery pain medication treated – Diagnosed with sleep apnea – with a high body mass index – About CovidienCovidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. [Read the rest of this entry...]